June 17th 2024
A recent review found that benzene exposure due to work may be linked to the development of colorectal cancer.
June 11th 2024
A dose escalation strategy for regorafenib could improve the cost-effectiveness of the medication in metastatic colorectal cancer (CRC).
June 3rd 2024
The Hospital Frailty Risk Score, Secondary Care Administrative Records Frailty index, and the frailty syndromes measures were able to assess frailty in patients diagnosed with colorectal cancer (CRC).
May 29th 2024
Clinical use of liquid biopsies to determine the likelihood of CRC is the goal based on its effectiveness in recent studies.
May 28th 2024
MicroRNAs could be a key to future testing for colorectal cancer (CRC) and determining treatment.